Division of Radiobiology and Molecular Environmental Research, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany.
FEBS Lett. 2010 Sep 24;584(18):3878-84. doi: 10.1016/j.febslet.2010.08.005. Epub 2010 Aug 7.
Nuclear localisation of EGFR is associated with treatment resistance of tumor cells. The aim of this study was to identify molecular targets to block nuclear shuttling of EGFR. Mutation of Thr654, located within the putative EGFR NLS demonstrated that phosphorylation of this residue is essential for nuclear EGFR shuttling following irradiation. Deletion of Thr654 blocked nuclear transport of EGFR, whereas mutation to Glu increased shuttling. Treatment with a peptide, corresponding to the phosphorylated NLS, abolished nuclear EGFR transport and reduced radiation-induced activation of DNA-PK, essential for DNA-repair. In accordance with that, lack of nuclear EGFR increased residual DNA damage in tumor cells and reduced cellular survival following irradiation. Blockage of nuclear EGFR shuttling may be a new strategy to fight treatment resistance.
EGFR 的核定位与肿瘤细胞的治疗抵抗有关。本研究的目的是确定阻止 EGFR 核穿梭的分子靶标。位于推定的 EGFR NLS 内的 Thr654 突变表明,该残基的磷酸化对于照射后 EGFR 的核穿梭至关重要。 Thr654 的缺失阻断了 EGFR 的核转运,而突变为 Glu 则增加了穿梭。用对应于磷酸化 NLS 的肽处理可消除核 EGFR 转运并减少 DNA-PK 的辐射诱导激活,DNA-PK 对 DNA 修复至关重要。与此一致,缺乏核 EGFR 会增加肿瘤细胞中的残留 DNA 损伤,并减少照射后的细胞存活。阻断核 EGFR 穿梭可能是对抗治疗抵抗的一种新策略。